- Acumen Powered by Robins Kaplan LLP™
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
July 21, 2021Benchmark Litigation Names Patrick Arenz and Aaron Fahrenkrog to its 40 & Under Hot List in 2021
-
July 20, 2021Five Robins Kaplan Firm Members Recognized by Minnesota Lawyer
-
July 19, 2021Robins Kaplan Attorneys Recognized as 2021 Minnesota Super Lawyers and Rising Stars
-
July 26, 2021Tee It up for the Troops
-
August 5, 2021Domesticating an Out of State Judgment in The State of Florida
-
August 6, 2021Mastering the Deposition: 30(b)(6) Deposition Strategies and Updates 2021
-
July 15, 2021Biotechnology & Trade Secret Protection
-
July 6, 2021'Abuse of dominance': Was this what Congress originally intended for Section 2?
-
Summer 2021Family Feud: A Cautionary Tale of the Costs, Risks, and Uncertainty of Minority-Shareholder Litigation
-
July 23, 2021Financial Daily Dose 7.23.2021 | Top Story: Amazon Abruptly Drops Mandatory Arbitration Requirement
-
July 22, 2021Financial Daily Dose 7.22.2021 | Top Story: Drug Companies Strike $26B Deal with State AGs Over Opioid Crisis
-
July 21, 2021Financial Daily Dose 7.21.2021 | Top Story: White House Names Google Critic Kanter to Lead DOJ Antitrust Division
The America Invents Act:
Changes in the Patent Laws of Special Interest to the Life Sciences Industry
November 4, 2011
After several years of unsuccessful attempts, Congress recently passed the Leahy-Smith America Invents Act (the ‘‘AIA’’),1 containing the most significant changes to the Patent Act in more than 60 years. President Obama signed the AIA into law on Sept. 16.2 This article presents an overview of the major provisions that are significant for practitioners in the life sciences.3
1 H.R. 1249 (112th Congress).
2 Pub. L. No. 112-29.
3 The authors recognize that there is no monolithic ‘‘life sciences industry’’ that speaks with one voice on all issues, but instead use this term to address views that may be common or shared among individuals and entities advancing or using technologies in the biomedical or biotechnological sciences.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
Related Professionals
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.